Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease

Miguel Cainzos-Achirica; Kershaw V. Patel; Renato Quispe; Parag H. Joshi; Amit Khera; Colby Ayers; Joao A.C. Lima; Jamal S. Rana; Philip Greenland; Marcio S. Bittencourt; Rhanderson Cardoso; Ron Blankstein; Roger S. Blumenthal; Michael J. Blaha; Khurram Nasir

doi:10.1016/j.jcmg.2020.12.024

Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease

Miguel Cainzos-Achirica, Kershaw V. Patel, Renato Quispe, Parag H. Joshi, Amit Khera, Colby Ayers, Joao A.C. Lima, Jamal S. Rana, Philip Greenland, Marcio S. Bittencourt, Rhanderson Cardoso, Ron Blankstein, Roger S. Blumenthal, Michael J. Blaha, Khurram Nasir

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Original language	English (US)
Pages (from-to)	1470-1472
Number of pages	3
Journal	JACC: Cardiovascular Imaging
Volume	14
Issue number	7
Early online date	Feb 2 2021
DOIs	https://doi.org/10.1016/j.jcmg.2020.12.024
State	Published - Jul 2021

Keywords

Calcium
Cardiovascular Diseases
Coronary Vessels/diagnostic imaging
Humans
Predictive Value of Tests
Primary Prevention

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.jcmg.2020.12.024

Cite this

Cainzos-Achirica, M., Patel, K. V., Quispe, R., Joshi, P. H., Khera, A., Ayers, C., Lima, J. A. C., Rana, J. S., Greenland, P., Bittencourt, M. S., Cardoso, R., Blankstein, R., Blumenthal, R. S., Blaha, M. J., & Nasir, K. (2021). Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease. JACC: Cardiovascular Imaging, 14(7), 1470-1472. https://doi.org/10.1016/j.jcmg.2020.12.024

Cainzos-Achirica, M, Patel, KV, Quispe, R, Joshi, PH, Khera, A, Ayers, C, Lima, JAC, Rana, JS, Greenland, P, Bittencourt, MS, Cardoso, R, Blankstein, R, Blumenthal, RS, Blaha, MJ & Nasir, K 2021, 'Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease', JACC: Cardiovascular Imaging, vol. 14, no. 7, pp. 1470-1472. https://doi.org/10.1016/j.jcmg.2020.12.024

@article{ff7cabe24c28404dbc1cead5ef483216,

title = "Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease",

keywords = "Calcium, Cardiovascular Diseases, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Primary Prevention",

author = "Miguel Cainzos-Achirica and Patel, {Kershaw V.} and Renato Quispe and Joshi, {Parag H.} and Amit Khera and Colby Ayers and Lima, {Joao A.C.} and Rana, {Jamal S.} and Philip Greenland and Bittencourt, {Marcio S.} and Rhanderson Cardoso and Ron Blankstein and Blumenthal, {Roger S.} and Blaha, {Michael J.} and Khurram Nasir",

note = "Funding Information: MESA: This research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201500003I and N01-HC-95159 through N01-HC-95169, and by National Center for Advancing Translational Sciences grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, and UL1-TR-001881. CARDIA was supported by NHLBI contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I. Dallas Heart Study: This work is supported in part by the National Center for Advancing Translational Science, National Institutes of Health grant UL1TR001105. Dr. Joshi has received grant funding from Novo Nordisk. Dr. Blaha has served on the advisory board of Novo Nordisk. Dr. Nasir has served on advisory boards for Amgen, Novartis, and The Medicine Company; and his research is partly supported by the Jerold B. Katz Academy of Translational Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Todd Villines, MD, served as the Guest Editor of this paper. The authors thank the other investigators, staff, and participants of the MESA, CARDIA, and Dallas Heart Study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . Funding Information: MESA: This research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201500003I and N01-HC-95159 through N01-HC-95169, and by National Center for Advancing Translational Sciences grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, and UL1-TR-001881. CARDIA was supported by NHLBI contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I. Dallas Heart Study: This work is supported in part by the National Center for Advancing Translational Science, National Institutes of Health grant UL1TR001105. Dr. Joshi has received grant funding from Novo Nordisk. Dr. Blaha has served on the advisory board of Novo Nordisk. Dr. Nasir has served on advisory boards for Amgen, Novartis, and The Medicine Company; and his research is partly supported by the Jerold B. Katz Academy of Translational Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the other investigators, staff, and participants of the MESA, CARDIA, and Dallas Heart Study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.",

year = "2021",

month = jul,

doi = "10.1016/j.jcmg.2020.12.024",

language = "English (US)",

volume = "14",

pages = "1470--1472",

journal = "JACC: Cardiovascular Imaging",

issn = "1936-878X",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease

AU - Cainzos-Achirica, Miguel

AU - Patel, Kershaw V.

AU - Quispe, Renato

AU - Joshi, Parag H.

AU - Khera, Amit

AU - Ayers, Colby

AU - Lima, Joao A.C.

AU - Rana, Jamal S.

AU - Greenland, Philip

AU - Bittencourt, Marcio S.

AU - Cardoso, Rhanderson

AU - Blankstein, Ron

AU - Blumenthal, Roger S.

AU - Blaha, Michael J.

AU - Nasir, Khurram

N1 - Funding Information: MESA: This research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201500003I and N01-HC-95159 through N01-HC-95169, and by National Center for Advancing Translational Sciences grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, and UL1-TR-001881. CARDIA was supported by NHLBI contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I. Dallas Heart Study: This work is supported in part by the National Center for Advancing Translational Science, National Institutes of Health grant UL1TR001105. Dr. Joshi has received grant funding from Novo Nordisk. Dr. Blaha has served on the advisory board of Novo Nordisk. Dr. Nasir has served on advisory boards for Amgen, Novartis, and The Medicine Company; and his research is partly supported by the Jerold B. Katz Academy of Translational Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Todd Villines, MD, served as the Guest Editor of this paper. The authors thank the other investigators, staff, and participants of the MESA, CARDIA, and Dallas Heart Study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . Funding Information: MESA: This research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201500003I and N01-HC-95159 through N01-HC-95169, and by National Center for Advancing Translational Sciences grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, and UL1-TR-001881. CARDIA was supported by NHLBI contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I. Dallas Heart Study: This work is supported in part by the National Center for Advancing Translational Science, National Institutes of Health grant UL1TR001105. Dr. Joshi has received grant funding from Novo Nordisk. Dr. Blaha has served on the advisory board of Novo Nordisk. Dr. Nasir has served on advisory boards for Amgen, Novartis, and The Medicine Company; and his research is partly supported by the Jerold B. Katz Academy of Translational Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the other investigators, staff, and participants of the MESA, CARDIA, and Dallas Heart Study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.

PY - 2021/7

Y1 - 2021/7

KW - Calcium

KW - Cardiovascular Diseases

KW - Coronary Vessels/diagnostic imaging

KW - Humans

KW - Predictive Value of Tests

KW - Primary Prevention

UR - http://www.scopus.com/inward/record.url?scp=85101693762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101693762&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2020.12.024

DO - 10.1016/j.jcmg.2020.12.024

M3 - Article

C2 - 33582063

AN - SCOPUS:85101693762

SN - 1936-878X

VL - 14

SP - 1470

EP - 1472

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

IS - 7

ER -

Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this